Background
Previous reports have implicated multiple genetic loci associated with atrial fibrillation (AF), but the contributions of genome-wide variation to AF susceptibility have not been quantified.
Methods and Results
We assessed the contribution of genome-wide single nucleotide polymorphism (SNP) variation to AF risk (SNP-heritability, h2g) using data from 120,286 unrelated individuals of European ancestry (2,987 with AF) in the population-based UK Biobank. We ascertained AF based on self-report, medical record billing codes, procedure codes, and death records. We estimated h2g using a variance components method with variants having a minor allele frequency (MAF) ≥1%. We evaluated h2g in age, sex, and genomic strata of interest. The h2g for AF was 22.1% (95% CI 15.6%–28.5%), and was similar for early- versus older-onset AF (≤65 versus >65 years of age) as well as for men and women. The proportion of AF variance explained by genetic variation was mainly accounted for by common (MAF ≥ 5%) variants (20.4%, 95% CI 15.1%–25.6%). Only 6.4% (95% CI 5.1–7.7%) of AF variance was attributed to variation within known AF susceptibility, cardiac arrhythmia, and cardiomyopathy gene regions.
Conclusions
Genetic variation contributes substantially to AF risk. The risk for AF conferred by genomic variation is similar to that observed for several other cardiovascular diseases. Established AF loci only explain a moderate proportion of disease risk, suggesting that further genetic discovery, with an emphasis on common variation, is warranted to understand the causal genetic basis of AF.